# Oxytocin and CBSST for People With Schizophrenia

> **NCT01752712** · NA · COMPLETED · sponsor: **University of Maryland, Baltimore** · enrollment: 83 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** CBSST + Oxytocin
- **DRUG:** CBSST + Placebo

## Key facts

- **NCT ID:** NCT01752712
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2019-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01752712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01752712, "Oxytocin and CBSST for People With Schizophrenia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01752712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*